Hydrochlorothiazide

Product NDC
72888-491
Requested package NDC
72888-491-01
11-digit product format
728880491
Labeler code
72888
Product ID
72888-491_5d541861-228e-17b0-e063-6394a90ab61e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Hydrochlorothiazide
Dosage form
SOLUTION
Route
ORAL
Labeler
Advagen Pharma Ltd
Application
ANDA218248
Marketing category
ANDA
Marketing start
2026-10-07
Substance
HYDROCHLOROTHIAZIDE
Active strength
50 mg/5mL
Pharmacologic classes
Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218248-001HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE50MG/5MLSOLUTION / ORALRS2026-10-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A218248-001HYDROCHLOROTHIAZIDE50MG/5MLSOLUTION / ORALRS2026-10-07d4dbc9d85df4…
2026-10-15 13:18:302026-09A218248-001HYDROCHLOROTHIAZIDE50MG/5MLSOLUTION / ORALRS2026-10-07c2088c7a36db…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Hydrochlorothiazide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYDROCHLOROTHIAZIDE50 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0J48LPH2THInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
310813Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
f4b10352-a923-4713-9d33-8f3636941b2eAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HydrochlorothiazideHYDROCHLOROTHIAZIDEAdvagen Pharma Ltdf4b10352-a923-4713-9d33-8f3636941b2e2026-10-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218248
application number: ANDA218248
ndc (package): 72888-491-01
ndc (product): 72888-491
ndc11 (package): 72888049101

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
72888-491-01728880491011 BOTTLE in 1 CARTON (72888-491-01) / 473 mL in 1 BOTTLE1 bottle2026-10-07NoNoCurrent